market research report : stem cell research market in india 2014

Insert Cover Image using Slide Master View

Do not distort

Stem Cell Research Market – India

June 2014

http://www.netscribes.com/


STEM CELL RESEARCH IN INDIA 2014.PPT

SAMPLE

2

Executive Summary

Market

Drivers & Challenges

Trends

Competition

• The Stem Cell Therapy market in India was valued at INR x1 bn in 2013 which is expected to reach INR x2 bn approximately by the year 2018

• The Cord Blood Cell Banking Market was worth INR y1 bn in 2013 and is expected to reach INR y2 bn by the year 2018

• India is projected to see a rise in the number of stem cell banks and stem cell depositors in the near future

•Increasing partnerships•Increasing investments

• Efforts to increase awareness in stem cell banking• Easy financing opportunities in stem cell banking

Major Players

Stem Cell Banks Company A Company B Company C

Stem Cell Research Organizations

Organization A Organization B Organization C

Challenges• High Cost of Therapy• Capital intensive nature of research

is decelerating the market• ‘Development Costs’ of Stem Cell

therapy resulting in slow progress of the market

Drivers:• Favorable Regulatory Environment• High Patient Population• Application in Drug Development• Increasing Awareness• Growing Medical Tourism• Increasing Health related Expenditure



STEM CELL RESEARCH IN INDIA 2014.PPT 3

•Macroeconomic Indicators•Introduction•Market Overview•Drivers & Challenges•Market Value Chain•Market Trends•Potential Stem Cell Sources•Government Participation•CompetitionStem Cell BanksResearch Organizations

•Recent Developments•Strategic Recommendations•Appendix




Economic Indicators (1/3)

11

12

13

14

15

b2

a2

Q1

d1c1

b1

a1

Q4

c4

b4

a4

Q3

c3

b3

a3

Q2

d2c2

INR tn

2013-142012-132011-122010-11

GDP at Factor Cost: Quarterly

Inflation Rate: Monthly

-2

-1

0

1

2

q

Jul 2013 - Aug 2013

p

%

Nov 2013 - Dec 2013

t

Oct 2013 - Nov 2013

s

Sep 2013 - Oct 2013

r

Aug 2013 - Sep 2013




SAMPLE Research supply companies are expected to earn huge profits by producing stem cells research products

• The global stem cell research sector is expected to

grow at a rate of x1% due to a number of reasons

Liberalization of stem cell research and government

support due to the rise in the incidence of chronic diseases

are the major factors aiding growth

• USA and China have the highest volume of stem cell

research and Singapore, Italy, USA, Japan, and Israel

have the highest level of activity in this area

• Globally, there are x2 companies involved in different

areas of stem cells research and the number is

expected to grow at a rate of x3% – x4%

• Well defined guidelines for stem cell research and

therapy have been developed by the US FDA & EMEA

while the South Asian / South East Asian countries

are yet to develop guidelines in this field

Global Market – Overview Stem Cell Therapy – Market Size and Growth

t

s

r

q

p

INR bn

X%

2018e

a6

2017e

a5

2016e

a4

2015e

a3

2014e

a2

2013

a1

u

t

s

r

q

p

Nos.

Y%

2013

x2

2005

x1

Number of Stem Cell Banks Worldwide




Stem cell therapy market is poised to grow at a very high rate due to increasing therapeutic applications

• The Stem Cell Therapy market in India was valued atINR x1 units in 20--

• The market is expected to reach INR x6 unitsapproximately by 20--, growing at a CAGR of X% forthis time period

• The stem cell research is a key factor that propels thetherapeutic market

• Almost m stem cell transplants are carried out inIndia annually that is growing gradually

Stem Cell Therapy Market – Overview Market Size and Growth

s

r

q

p

0

INR units

X%

20--e

x6

20--e

x5

20--e

x4

20--e

x3

20--e

x2

20--

x1

20--

x0

• The Stem Cell Banking Market was worth INR y1units in 20-- and is expected to reach INR y6 units in20--

• The stem cell banking market is expected to exhibit aCAGR of Y% between 20-- and 20--

• Stem cell banking that was unheard of a few yearsback but has become popular in the recent past as aless traumatic alternative to treat neurologicaldiseases and as guarantee for the entire familyagainst several other diseases

Stem Cell Banking Market – Overview

t

s

r

q

p

0

20--

y0

INR units

Y%

20--e

y6

20--e

y5

20--e

y4

20--e

y3

20--e

y2

20--

y1

Market Size and Growth



STEM CELL RESEARCH IN INDIA 2014.PPT 7

Drivers & Challenges – Summary

Drivers

Favorable Regulatory Environment

High Patient Population

Application in Drug Development

Increasing Awareness

Growing Medical Tourism

Increasing R&D Expenditure

Challenges

High Cost of Therapy

Capital Intensive Market

High Development Cost




SAMPLE

8

Easy financing opportunities in stem cell banking

Increasing Partnerships

Efforts to increase awareness in stem cell

Increasing Investments

Key Trends

Trends – Summary




SAMPLE Porter’s Five Forces Analysis

Competitive RivalryBargaining Power of SuppliersBargaining Power of Buyers

Threat of Substitutes

Threat of New Entrants

Impactx

Impactx

Impactx

Impactx

Impactx

*Note: BEP (Break-even point)




SAMPLE Key Ratios of Top 3 Companies – Operational Basis (FY 2013) (1/3)

Competitive Benchmarking (2/5)

0

10

20

30

40

%

Company C

b3a3

Company B

b2a2

Company A

b1

a1

Operating Margin Net Margin

• Company A recorded operating margin of x1%, higher than that of Company B which recorded operating margin of y2% but lower than that of Company C which recorded operating margin of z3%

• Net margin for Company A , Company B and Company C are a1%, b2% and c3% respectively, wherein Company A has the highest net margin among these three companies




SAMPLE Public: Domestic Company – Company 1(1/5)

Key People

Products and Services

Company Information Offices and Centres – India

Corporate Address

Tel No.

Fax No.

Website

Year of Incorporation

Ticker Symbol

Stock Exchange

Name Designation

Person 1 MD and Executive Director

Person 2VC and VC of Share Transfer Committee

Person 3 Director

Person 4 Director

Head OfficeMumbai

Category Products/Services




SAMPLE Financial Snapshot Key Ratios

Financial Summary

• The company earned a net profit of INR x1 mn in FY 2013, as compared to net profit of INR x2 mn in FY 2012

• The company reported total income of INR y1 mn in FY 2013, registering an increase of y2% over FY 2012

• The company earned an operating margin of z1% in FY 2013, an increase of z2percentage points over FY 2012

• The company reported debt to equity ratio of a1 in FY 2013, an increase of a3% over FY 2012

Key Financial Performance Indicators

Indicators Value (20/03/2014)

Particulars y-o-y change

(2013-12)2013 2012 2011 2010

Profitability RatiosOperating Margin

Net Margin

Profit Before Tax Margin

Return on Equity

Return on Capital Employed

Return on Working Capital

Return on Assets

Return on Fixed Assets

Cost RatiosOperating costs (% of Sales)

Administration costs (% of Sales)

Interest costs (% of Sales)

Liquidity RatiosCurrent Ratio

Cash Ratio

Leverage RatiosDebt to Equity Ratio

Debt to Capital Ratio

Interest Coverage Ratio

Efficiency RatiosFixed Asset Turnover

Asset Turnover

Current Asset Turnover

Working Capital Turnover

Capital Employed Turnover

Improved Decline

Net Profit/LossTotal Income

e

d

c

b

a

s

r

q

p

2013

a4

z4

2012

a3

z3

2011

a2

z2

2010

a1

z1

Public: Domestic Company – Company 1(2/5)




SAMPLE Public: Domestic Company – Company 1(3/5)Key Business Segments Key Geographic Segments

A%

B%

C%

2013

b4%

2012

b3%

2011

b2%

2010

b1%

a1% C%

B%

A%

2010

y1%

x1%

2013

x4%

2012

x3%

2011

x2%

Region 2Region 1

Business Highlights

Segment 2Segment 1

Description News

Overview• The company has operations in Country A, Country B and Country C that offers treatment for acute and

chronic diseases in primary, secondary and tertiary care sectors

Services

• Specializes in 50 specialties comprising cardiac sciences, oncology, radiology and imaging, gastroenterology, neurosciences, orthopedics, critical care services and in minimally invasive surgeries and transplantation

• Operates retail pharmacy outlets all across the country




SAMPLE

TO

WS

Public: Domestic Company – Company 1 – SWOT Analysis (5/5)




SAMPLE Private: Domestic Company – Company 2(1/5)

Key People

Products and Services

Company Information Offices and Centres – India

Name Designation

Person 1 Director

Person 2 Director

Person 3 Director

Person 4 Director

Corporate Address

Tel No.

Fax No.

Website

Year of Incorporation Head Office

Category Products/Services

Ready Meals

Instant Mixes

Others

Mumbai




SAMPLE Private: Domestic Company – Company 2(2/5)

Shareholders of the Company Ownership Structure

Name No. of Shares held

23.6%57.4%

19.0%

Segment

Segment

Segment




SAMPLE

READY TO EAT MARKET IN INDIA 2014.PPT

Financial Snapshot Key Ratios

Particulars y-o-y change

(2013-12)2013 2012 2011 2010

Profitability RatiosOperating Margin

Net Margin

Profit Before Tax Margin

Return on Equity

Return on Capital Employed

Return on Working Capital

Return on Assets

Return on Fixed Assets

Cost RatiosOperating costs (% of Sales)

Administration costs (% of Sales)

Interest costs (% of Sales)

Liquidity RatiosCurrent Ratio

Cash Ratio

Leverage RatiosDebt to Equity Ratio

Debt to Capital Ratio

Interest Coverage Ratio

Efficiency RatiosFixed Asset Turnover

Asset Turnover

Current Asset Turnover

Working Capital Turnover

Capital Employed Turnover

Private: Domestic Company – Company 2(3/5)

Improved Decline

Financial Summary

• The company earned a net profit of INR x1 mn in FY 2011, as

compared to net profit of INR x2 mn in FY 2010

• The company reported total income of INR x3 mn in FY 2011,

registering an increase of x4% over FY 2010

• The company earned an operating margin of x5% in FY 2011,

an increase of x6 percentage points over FY 2010

• The company reported debt to equity ratio of x7 in FY 2011, a

decrease of x8% over FY 2010

Net Profit/LossTotal Income

a

t

s

r

q

f

p

b

c

d

e

b4

a4

20112008

a1

b1

2010

a3

b3

2009

a2

b2




SAMPLE

18

Description News

Overview• Company 2 has hospital network in Country A, Country B and Country C and is primarily headquartered in

Country D

• Presently located in 10 cities in India having hospitals in Region 1, Region 2 and Region 3

Facilities• Has core specialties in heart care, brain and spine, bone and joint and minimal access surgery

• Provides advanced medical diagnostics and treatment with personal care

Recognitions• Obtained NABH accreditation within one and a half years of beginning operation in India

• Hospital A, Region 1, Hospital B, Region 2 has been NABH accredited

Business Highlights

Private: Domestic Company – Company 2(3/5)




SAMPLE

TO

WS

Private: Domestic Company – Company 2– SWOT Analysis (5/5)




Thank you for the attention

About Netscribes, Inc.Netscribes, Inc. is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one-stop shop designed to fulfil clients’ profitability and growth objectives.

Stem Cell Research Market in India 2014– India report is part of Netscribes’ Healthcare Series.For any queries or customized research requirements, contact us at:

Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction.

Phone: +91 22 4098 7600E-Mail: [email protected]





mailto:[email protected]